Aerobe provides cutting-edge technology and scientific expertise to support researchers and clinicians in their endeavour to find novel approaches and innovative solutions in a range of disciplines.
We are a goal focused and process driven company, helping us command a high level of professional reputation and goodwill with all our stakeholders.
An advanced high-performance TMS magnetic stimulator designed primarily for clinical use as well as research. The MagPro R30 performs repetitive transcranial magnetic stimulation and runs many complex protocols successively; up to 20,000 pulses in one session
The LiveAmp is a wearable, 24-bit amplifier – available with 8, 16, 32 and also with 64 channels. As it is wireless and allows you to store your recorded data internally (i.e. on an exchangeable memory card), there are no mobility limitations.
Transcranial Pulse Stimulation (TPS) is a revolutionary new technique that delivers short acoustic pulses with an ultrasound frequency range. The technique allows unprecedented focal brain stimulation reaching depths of as much as 8 cm in the brain. Developed by Storz Medical, the system (NEUROLITH ®) reflects a unparalleled advancement in the field of transcranial stimulation.
The NIRSport 2 is a user-friendly, modular, and robust wireless functional near-infrared spectroscopy (fNIRS) platform which measures hemodynamic responses to neuroactivation via oxy-, deoxy-, and total hemoglobin changes in the cerebral cortex.
The NIRSport 2 comes with a host of ready-to-implement upgrades and modules to meet the needs of a broad range of cognitive neuroscience applications.
The CXS sensor unit (CODA unit) is capable of operating in bright sunlight up to 90,000 Lux.
The CXS combines three motion sensing arrays into one unit. This allows a standalone CXS unit to make a complete 3D measurement without reference to any other units. It also means that the unit can be pre-calibrated and sealed. All the user does is to point the unit at the action.
Designed with user workflow and IT standards in mind, the MYOQUICK EMG-EP system features a color coded Human Interface Device, programmable foot pedal and active handheld stimulator that maximizes efficiency and increases patient comfort.
The Soterix Medical 1×1 was developed by clinical researchers, scientists, and biomedical engineers to provide all clinical standard tDCS protocols. Current intensity from 0.1 to 2 mA (5 mA option available upon request), and current duration from 5 to 40 minutes. Stimulation set-up is straight-forward with the simple to set-up Open-Panel™ controls, 1×1 electrode accessories, and SmartScan™ indicator. The tDCS 1×1 features allow you to focus on the subject and experiment, not the device.
Medoc Q-Sense is a portable, easy-to-use and affordable quantitative sensory testing (QST) device for clinical, research and pharmacologic trial use.
Q-Sense offers scientifically validated measures of warm, cool and heat-pain thermal sensory thresholds. All of these can be useful determinants in the evaluation of peripheral sensory nerve function, neuropathic pain, diabetic, chemotherapeutic, and other small-fiber neuropathies.
The Quest HD+Stim provides extensive tES capabilities, including tDCS, tACS, tPCS and tRNS.
Extensive software APIs give you the freedom to experiment with customized and novel waveforms. Modulate experimental stimuli based on your subject’s behavioral/electrophysiological responses with the powerful on-board processing of the Quest HD+Stim.
With all of the mobility and recording features of the Quest HD, the Quest HD+Stim can perform HD tES & record HD EEG in up to 256-channel configurations.
The EyeBrain T2 is a medical device measuring eye and head movements.
It was designed to assist in the diagnosis of neurological and psychiatric diseases and reading disorders.
Severals test are available to assess parameters as latency, speed and precision during saccads.
The EyeBrain Trackers innovate by enabling patient test results to be compared to normative values in the same way as a blood test.
With its slim design, high definition 40” display and superior picture quality, the InroomViewingDevice is the optimal choice for an easy-to-use alternative to conventional projectors or goggle-based image delivery systems.
This is the ideal tool to provide images or video inside the MRI scan room.
We are committed to provide the best Customer Support in the Industry. A sale is not an end, rather it is a beginning of a relationship for Aerobe. We believe that a satisfied customer is the best Sales reference.
Facts about us-
There are various forms of brain stimulation, that are used in neurodegenerative disease. In this webinar neurologist Dr Lars Wojtecki talks about scientific background and clinical data of Transcranial Pulse Stimulation as well as practical experience with handling and clinical effects. Which patient to choose? How does TPS compare to TMS?
Prof. Dr Roland Beisteiner from Medical University Vienna delves into the latest science on Transcranial Pulse Stimulation (TPS) with NEUROLITH® system, the research behind it, his work and the success to date. This new technique allows unprecedented focal neuronal tissue stimulation reaching depths of as much as 8 cm in the brain and reflects an unparalleled advancement in the field of transcranial stimulation.
Patellofemoral pain (PFP) is considered a mechanistic pain syndrome, originating from kinetic, anatomic or biomechanical dysfunction leading to nociceptive pain. However, some data shows that not all pain expressions in patients with PFP can be causatively connected to a biomechanical impairment.
Transcranial Pulse Stimulation (TPS®) for the treatment of Alzheimer's patients is now also available for patients in Switzerland. In early February 2021, the first NEUROLITH® system was successfully installed in the Praxis Alexander Russ in Zurich.
Recording of session »Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment« by Dr Pavel Novak Due to the high demand at Dementia 2021 virtual meeting Dr Pavel Novak has agreed to offer his lecture on the topic »Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment« for STORZ MEDICAL partners.
New CNS Monitor software is now available! This update to the CNS Monitor includes support for collecting data from the Sophysa Pressio 2 and Multigon TCD System.
The past 5 years have seen a surge in innovation and global productivity in FUS clinical efforts, with the demonstration of a favourable safety profile as well as versatility across and scalability within several clinical indications. Following regulatory approval of MRgFUS thalamotomy for ET and tremor-dominant PD, thermoablation has gone from experimental treatment to standard of care. Efficacy data for drug delivery via FUS BBBO are anticipated over the next 2 years, probably within the neuro-oncology field initially. Additionally, a growing number of registered trials are addressing the application of FUS neuromodulation in epilepsy, AD, PD, depression and traumatic brain injury.
Ultium Motion, Noraxon’s next-generation inertial motion capture system, is equipped with a patent-pending state-of-the-art sensor design that delivers accurate & reliable kinematic data for all types of movement – including high velocity and high impact conditions – while maintaining the advantages of the multi-device myoRESEARCH software platform through the universal connectivity of the Ultium receiver.
This study proposes a feature selection method that can obtain feature subsets for HAR as well as a sensor-to-segment coordinate alignment algorithm and a joint angle estimation algorithm. Comparing with other feature selection algorithms, the proposed algorithm can greatly discard features and maintain comparable classification performance. The sensor coordinate calibration algorithm is proved to be beneficial for HAR.
Sally Crawford of Resilience Code uses a Kintread Pressure Treadmill to dynamically measure feet through entire heel to toe contact in order to help improve overall foot health with comfortable shoes & optimal orthotics. Pairing barefoot dynamic structure and footwear....in motion. A static shoe or orthotic fit to match one frame of gait is good but what if you can measure dynamically through entire heel to toe contact and pair to your most ...
The first workshop will take place from 22nd – 26th March on five consecutive half-days, in the time zone that works best for Europe and Asia. The workshop is free of charge. The participant limit is 30 participants per day. There are many exciting new features in BESA Research and its sister products which will be covered extensively. BESA brings you a fresh workshop format with shorter plenary sessions and more hands-on user interaction, where you can work on your own tasks with the help of our experienced tutors.
Patients with CLBP demonstrated different phenotypes of endogenous pain modulation. In patients with reduced conditioned pain modulation, tapentadol produced long-term pain relief that coincided with reduction of signs of pain facilitation. These data indicate that the endogenous pain system may be used as a biomarker in the pharmacological treatment of CLBP, enabling an individualized, mechanism-based treatment approach.
There are various forms of brain stimulation, that are used in neurodegenerative disease. In this webinar neurologist Dr Lars Wojtecki talks about scientific background and clinical data of Transcranial Pulse Stimulation as well as practical experience with handling and clinical effects. Which patient to choose? How does TPS compare to TMS?
Patellofemoral pain (PFP) is considered a mechanistic pain syndrome, originating from kinetic, anatomic or biomechanical dysfunction leading to nociceptive pain. However, some data shows that not all pain expressions in patients with PFP can be causatively connected to a biomechanical impairment.
Transcranial Pulse Stimulation (TPS®) for the treatment of Alzheimer's patients is now also available for patients in Switzerland. In early February 2021, the first NEUROLITH® system was successfully installed in the Praxis Alexander Russ in Zurich.
Transcranial Pulse Stimulation (TPS®) for the treatment of Alzheimer's patients is now also available for patients in Switzerland. In early February 2021, the first NEUROLITH® system was successfully installed in the Praxis Alexander Russ in Zurich.
New CNS Monitor software is now available! This update to the CNS Monitor includes support for collecting data from the Sophysa Pressio 2 and Multigon TCD System.
Ultium Motion, Noraxon’s next-generation inertial motion capture system, is equipped with a patent-pending state-of-the-art sensor design that delivers accurate & reliable kinematic data for all types of movement – including high velocity and high impact conditions – while maintaining the advantages of the multi-device myoRESEARCH software platform through the universal connectivity of the Ultium receiver.
There are various forms of brain stimulation, that are used in neurodegenerative disease. In this webinar neurologist Dr Lars Wojtecki talks about scientific background and clinical data of Transcranial Pulse Stimulation as well as practical experience with handling and clinical effects. Which patient to choose? How does TPS compare to TMS?
Prof. Dr Roland Beisteiner from Medical University Vienna delves into the latest science on Transcranial Pulse Stimulation (TPS) with NEUROLITH® system, the research behind it, his work and the success to date. This new technique allows unprecedented focal neuronal tissue stimulation reaching depths of as much as 8 cm in the brain and reflects an unparalleled advancement in the field of transcranial stimulation.
Recording of session »Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment« by Dr Pavel Novak Due to the high demand at Dementia 2021 virtual meeting Dr Pavel Novak has agreed to offer his lecture on the topic »Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment« for STORZ MEDICAL partners.
Patellofemoral pain (PFP) is considered a mechanistic pain syndrome, originating from kinetic, anatomic or biomechanical dysfunction leading to nociceptive pain. However, some data shows that not all pain expressions in patients with PFP can be causatively connected to a biomechanical impairment.
The past 5 years have seen a surge in innovation and global productivity in FUS clinical efforts, with the demonstration of a favourable safety profile as well as versatility across and scalability within several clinical indications. Following regulatory approval of MRgFUS thalamotomy for ET and tremor-dominant PD, thermoablation has gone from experimental treatment to standard of care. Efficacy data for drug delivery via FUS BBBO are anticipated over the next 2 years, probably within the neuro-oncology field initially. Additionally, a growing number of registered trials are addressing the application of FUS neuromodulation in epilepsy, AD, PD, depression and traumatic brain injury.
This study proposes a feature selection method that can obtain feature subsets for HAR as well as a sensor-to-segment coordinate alignment algorithm and a joint angle estimation algorithm. Comparing with other feature selection algorithms, the proposed algorithm can greatly discard features and maintain comparable classification performance. The sensor coordinate calibration algorithm is proved to be beneficial for HAR.
We provide solutions for healthcare and research. We distribute medical equipment, provide scientific expertise and support to researcher
© 2020 Aerobe. All Rights Reserved Terms & Conditions | Privacy Policy